Vivos (RDGL) Cash from Financing Activities (2010 - 2025)

Vivos' (RDGL) quarterly Cash from Financing Activities came in at -$845.0 in Q4 2025, down 100.06% year-on-year from $1.5 million in Q4 2024, and down 100.06% quarter-over-quarter from $1.5 million in Q1 2025.

Vivos (RDGL) Cash from Financing Activities (2010 - 2025) Analysis & Trends

Vivos has disclosed Cash from Financing Activities across 15 years of filings, most recently posting -$845.0 for Q4 2025.

  • Cash from Financing Activities for Q4 2025 came in at -$845.0, down 100.06% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 million (down 34.6% YoY), and the FY2025 annual result was $1.5 million, down 34.6% from the prior year.
  • Cash from Financing Activities came in at -$845.0 for Q4 2025 at Vivos, down from $1.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $1.8 million in Q1 2021 to a low of -$145000.0 in Q4 2021.
  • The 4-year median for Cash from Financing Activities is $518580.0 (2023), against an average of $667335.9.
  • Peak annual rise in Cash from Financing Activities reached 2420.16% in 2021, while the deepest fall reached 111.56% in 2021.
  • Vivos' Cash from Financing Activities stood at -$145000.0 in 2021, then surged by 457.64% to $518580.0 in 2023, then jumped by 182.56% to $1.5 million in 2024, then sank by 100.06% to -$845.0 in 2025.
  • The last three Cash from Financing Activities figures came in at -$845.0 (Q4 2025), $1.5 million (Q1 2025), and $1.5 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 17.31 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -1.51 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -451.20 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 21.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -25.00 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -97.90 Mn
10 Vivos - - -3,105.00 -845.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -845.00
Dec 31, 2025 -845.00
Mar 31, 2025 1.51 Mn
Mar 31, 2025 1.51 Mn
Dec 31, 2024 1.47 Mn
Dec 31, 2024 1.47 Mn
Jun 30, 2024 709,000.00
Jun 30, 2024 709,000.00
Mar 31, 2024 130,000.00
Mar 31, 2024 130,000.00
Dec 31, 2023 518,580.00
Dec 31, 2023 518,580.00
Sep 30, 2023 10,000.00
Sep 30, 2023 10,000.00
Dec 31, 2021 -145,000.00
Dec 31, 2021 -145,000.00
Mar 31, 2021 1.81 Mn
Mar 31, 2021 1.81 Mn
Dec 31, 2020 1.25 Mn
Dec 31, 2020 1.25 Mn